A triad of studies from the annual San Antonio Breast Cancer Symposium brings welcome word from the breast cancer research arena.
Might there be a relationship between Alzheimer’s disease and levels within the body of the good cholesterol, high-density lipoprotein (HDL)?Today’s edition of the Archives of Neurology includes a study performed at Columbia Univers
Media darling and Duke University Global Health Initiative Professor Eric Finkelstein is back in the news with the release of a report in The Archives of Internal Medicine in which he and three colleagues present economic models in support of taxes on sugar-sweetened beverages (SSBs).
The risk of both early- and late-onset macular degeneration (AMD), the leading cause of blindness, increases with age but can be prevented, a new study published in the journal Opthalmology finds. After taking detailed images of the interior of the eyes of 5,272 people in Iceland aged 66 and older, researchers found that 11 percent of those in their late 60s had an early form of AMD, and this rate increased to 36 percent for people 85 and older.
Children who have no smokers in their families but who reside in apartment buildings have higher levels of cotinine, a by-product of tobacco smoke, in their blood than similar children who dwell in detached, single-family homes, a new study in the journal Pediatrics finds. After surveying and taking blood samples of children between the ages of 6 and 18 from 2001 to 2006 who live in smoke-free homes, study author Dr.
Starting yesterday, the Global Alliance for Vaccines and Immunization (GAVI) launched a pneumococcal vaccination campaign in Nicaragua that aims to prevent 700,000 deaths in poorer nations by 2015. Drug makers Pfizer and GlaxoSmithKline signed a 10-year contract with GAVI and will supply 60 million doses of their pneumococcal shots — Pfizer’s Prevnar and GSK’s Synflorix — for a discounted price of $7 per dose for the first 20 percent and $3.50 per dose for the remaining 80 percent.
There are no adverse health effects associated with the low-level amounts of mercury found in dental fillings, the FDA determined less than 18 months ago. This conclusion was supported by the American Dental Association.
The FDA’s stringent conflict-of-interest policies are impeding research, ACSH’s Dr. Elizabeth Whelan writes in her latest op-ed published yesterday in the Richmond News-Dispatch. Dr.
Originally published in the Richmond Times-Dispatch.
When an FDA panel voted to reject a new weight-loss drug this fall, many observers were outraged.
Researchers have stumbled upon an alternate explanation for the buildup of the protein amyloid β in the brains of Alzheimer’s disease patients.
